Haleon UK Holding Sri Lanka Limited

Company Name	Haleon UK Holding Sri Lanka Limited
Company Status	Active
Company Number	09400298
Category	Private Limited Company
Incorporation Date	21 January 2015(9 years, 3 months ago)
Previous Name	Glaxosmithkline Consumer Healthcare Sri Lanka Holdings Limited

Business Activity

Section K	Financial and insurance activities
SIC 64209	Activities of other holding companies n.e.c.

Directors

Director Name	Miss Rebecca Jane Leeke
Date of Birth	June 1989 (Born 34 years ago)
Nationality	British
Status	Current
Appointed	04 March 2022(7 years, 1 month after company formation)
Appointment Duration	2 years, 1 month
Role	Chartered Accountant
Country of Residence	England
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr Lee Di Pietro
Date of Birth	November 1986 (Born 37 years ago)
Nationality	Australian
Status	Current
Appointed	04 March 2022(7 years, 1 month after company formation)
Appointment Duration	2 years, 1 month
Role	Accountant
Country of Residence	United Kingdom
Correspondence Address	Building 5, First Floor The Heights Weybridge Surrey KT13 0NY

Director Name	GSK Consumer Healthcare Holdings No.4 Limited (Corporation)
Status	Current
Appointed	06 April 2022(7 years, 2 months after company formation)
Appointment Duration	2 years
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	GSK Consumer Healthcare Holdings No.8 Limited (Corporation)
Status	Current
Appointed	06 April 2022(7 years, 2 months after company formation)
Appointment Duration	2 years
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Haleon UK Corporate Secretary Limited (Corporation)
Status	Current
Appointed	06 April 2022(7 years, 2 months after company formation)
Appointment Duration	2 years
Correspondence Address	Building 5 First Floor The Heights Weybridge Surrey KT13 0NY

Director Name	Haleon UK Corporate Director Limited (Corporation)
Status	Current
Appointed	06 April 2022(7 years, 2 months after company formation)
Appointment Duration	2 years
Correspondence Address	Building 5 First Floor The Heights Weybridge Surrey KT13 0NY

Director Name	Mr Paul Frederick Blackburn
Date of Birth	October 1954 (Born 69 years ago)
Nationality	British
Status	Resigned
Appointed	21 January 2015(same day as company formation)
Role	Financial Controller
Country of Residence	England
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr Adam Walker
Date of Birth	November 1967 (Born 56 years ago)
Nationality	British
Status	Resigned
Appointed	03 June 2015(4 months, 1 week after company formation)
Appointment Duration	1 year, 2 months (resigned 01 August 2016)
Role	Company Director
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr Jonathan Wilson Box
Date of Birth	March 1963 (Born 61 years ago)
Nationality	British
Status	Resigned
Appointed	17 June 2016(1 year, 4 months after company formation)
Appointment Duration	1 year, 5 months (resigned 30 November 2017)
Role	Cfo Consumer Healthcare, Glaxosmithkline
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mrs Melanie Foster-Hawes
Date of Birth	January 1975 (Born 49 years ago)
Nationality	British
Status	Resigned
Appointed	17 June 2016(1 year, 4 months after company formation)
Appointment Duration	2 years, 7 months (resigned 15 January 2019)
Role	Accountant
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Richard Philip Tattershall
Date of Birth	October 1982 (Born 41 years ago)
Nationality	British
Status	Resigned
Appointed	30 November 2017(2 years, 10 months after company formation)
Appointment Duration	2 years, 3 months (resigned 10 March 2020)
Role	Accountant
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr Richard Green
Date of Birth	October 1974 (Born 49 years ago)
Nationality	British
Status	Resigned
Appointed	15 January 2019(3 years, 12 months after company formation)
Appointment Duration	1 year, 1 month (resigned 10 March 2020)
Role	Company Director
Country of Residence	England
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr Antrinkos Andrew Aristidou
Date of Birth	June 1968 (Born 55 years ago)
Nationality	British
Status	Resigned
Appointed	19 August 2019(4 years, 7 months after company formation)
Appointment Duration	11 months, 2 weeks (resigned 31 July 2020)
Role	Chartered Accountant
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr Nicholas Ian Cooper
Date of Birth	July 1972 (Born 51 years ago)
Nationality	British
Status	Resigned
Appointed	11 September 2019(4 years, 7 months after company formation)
Appointment Duration	2 years, 5 months (resigned 04 March 2022)
Role	Accountant
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr David John Cottam
Date of Birth	April 1963 (Born 61 years ago)
Nationality	British
Status	Resigned
Appointed	31 July 2020(5 years, 6 months after company formation)
Appointment Duration	1 year, 7 months (resigned 04 March 2022)
Role	Finance Director
Country of Residence	England
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mrs Rebecca Jane Agnew
Date of Birth	June 1989 (Born 34 years ago)
Nationality	British
Status	Resigned
Appointed	04 March 2022(7 years, 1 month after company formation)
Appointment Duration	1 year, 11 months (resigned 29 January 2024)
Role	Chartered Accountant
Country of Residence	England
Correspondence Address	Building 5, First Floor The Heights Weybridge Surrey KT13 0NY

Director Name	The Wellcome Foundation Limited (Corporation)
Status	Resigned
Appointed	21 January 2015(same day as company formation)
Correspondence Address	980 Great West Road Brentford TW8 9GS

Director Name	Glaxo Group Limited (Corporation)
Status	Resigned
Appointed	21 January 2015(same day as company formation)
Correspondence Address	980 Great West Road Brentford TW8 9GS

Secretary Name	Edinburgh Pharmaceutical Industries Limited (Corporation)
Status	Resigned
Appointed	21 January 2015(same day as company formation)
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Contact

Website	gsk.com
Telephone	01280 000000
Telephone region	Buckingham

Location

Registered Address	Building 5, First Floor The Heights Weybridge Surrey KT13 0NY
Region	South East
Constituency	Runnymede and Weybridge
County	Surrey
Ward	Weybridge St George's Hill
Built Up Area	Greater London
Address Matches	Over 20 other UK companies use this postal address

Shareholders

100 at £1	Setfirst LTD 100.00% Ordinary

Accounts

Latest Accounts	31 December 2022 (1 year, 3 months ago)
Next Accounts Due	30 September 2024 (5 months from now)
Accounts Category	Audit Exemption Subsidiary
Accounts Year End	31 December

Returns

Latest Return	24 May 2023 (11 months, 1 week ago)
Next Return Due	7 June 2024 (1 month, 1 week from now)

Filing History

7 November 2023	Change of details for Haleon Uk Services Limited as a person with significant control on 18 July 2022 (2 pages)
17 August 2023	Consolidated accounts of parent company for subsidiary company period ending 31/12/22 (235 pages)
17 August 2023	Audit exemption statement of guarantee by parent company for period ending 31/12/22 (3 pages)
17 August 2023	Notice of agreement to exemption from audit of accounts for period ending 31/12/22 (1 page)
17 August 2023	Audit exemption subsidiary accounts made up to 31 December 2022 (18 pages)
5 June 2023	Director's details changed for Haleon Uk Corporate Director Limited on 18 July 2022 (1 page)
5 June 2023	Director's details changed for Haleon Uk Corporate Secretary Limited on 18 July 2022 (1 page)
5 June 2023	Change of details for Haleon Uk Services Limited as a person with significant control on 18 July 2022 (2 pages)
5 June 2023	Secretary's details changed for Haleon Uk Corporate Secretary Limited on 18 July 2022 (1 page)
25 May 2023	Confirmation statement made on 24 May 2023 with updates (4 pages)
24 May 2023	Notice of agreement to exemption from audit of accounts for period ending 31/12/22 (1 page)
24 May 2023	Audit exemption statement of guarantee by parent company for period ending 31/12/22 (3 pages)
19 May 2023	Secretary's details changed for Gsk Consumer Healthcare Holdings No.8 Limited on 31 March 2023 (1 page)
19 May 2023	Director's details changed for Gsk Consumer Healthcare Holdings No.4 Limited on 31 March 2023 (1 page)
19 May 2023	Director's details changed for Gsk Consumer Healthcare Holdings No.8 Limited on 31 March 2023 (1 page)
14 April 2023	Company name changed glaxosmithkline consumer healthcare sri lanka holdings LIMITED\certificate issued on 14/04/23 NM01 ‐ Change of name by resolution RES15 ‐ Change company name resolution on 2023-04-06 (3 pages)
31 January 2023	Director's details changed for Miss Rebecca Jane Leeke on 30 January 2023 (2 pages)
25 November 2022	Change of details for Glaxosmithkline Consumer Healthcare (Overseas) Limited as a person with significant control on 18 November 2022 (2 pages)
15 August 2022	Director's details changed for Mr Lee Di Pietro on 7 July 2022 (2 pages)
18 July 2022	Registered office address changed from 980 Great West Road Brentford Middlesex TW8 9GS United Kingdom to Building 5, First Floor the Heights Weybridge Surrey KT13 0NY on 18 July 2022 (1 page)
20 June 2022	Notice of agreement to exemption from audit of accounts for period ending 31/12/21 (1 page)
20 June 2022	Audit exemption statement of guarantee by parent company for period ending 31/12/21 (3 pages)
20 June 2022	Audit exemption subsidiary accounts made up to 31 December 2021 (19 pages)
20 June 2022	Consolidated accounts of parent company for subsidiary company period ending 31/12/21 (316 pages)
24 May 2022	Confirmation statement made on 24 May 2022 with no updates (3 pages)
6 April 2022	Termination of appointment of Glaxo Group Limited as a director on 6 April 2022 (1 page)
6 April 2022	Termination of appointment of Edinburgh Pharmaceutical Industries Limited as a secretary on 6 April 2022 (1 page)
6 April 2022	Appointment of Gsk Consumer Healthcare Holdings No.4 Limited as a director on 6 April 2022 (2 pages)
6 April 2022	Appointment of Gsk Consumer Healthcare Holdings No.8 Limited as a secretary on 6 April 2022 (2 pages)
6 April 2022	Appointment of Gsk Consumer Healthcare Holdings No.8 Limited as a director on 6 April 2022 (2 pages)
6 April 2022	Termination of appointment of the Wellcome Foundation Limited as a director on 6 April 2022 (1 page)
9 March 2022	Termination of appointment of David John Cottam as a director on 4 March 2022 (1 page)
9 March 2022	Appointment of Mr Lee Di Pietro as a director on 4 March 2022 (2 pages)
9 March 2022	Appointment of Miss Rebecca Jane Leeke as a director on 4 March 2022 (2 pages)
9 March 2022	Termination of appointment of Nicholas Ian Cooper as a director on 4 March 2022 (1 page)
25 January 2022	Confirmation statement made on 19 January 2022 with no updates (3 pages)
6 July 2021	Audit exemption subsidiary accounts made up to 31 December 2020 (18 pages)
25 May 2021	Audit exemption statement of guarantee by parent company for period ending 31/12/20 (3 pages)
25 May 2021	Consolidated accounts of parent company for subsidiary company period ending 31/12/20 (304 pages)
25 May 2021	Notice of agreement to exemption from audit of accounts for period ending 31/12/20 (1 page)
19 January 2021	Confirmation statement made on 19 January 2021 with no updates (3 pages)
12 August 2020	Appointment of Mr David John Cottam as a director on 31 July 2020 (2 pages)
11 August 2020	Termination of appointment of Antrinkos Andrew Aristidou as a director on 31 July 2020 (1 page)
27 May 2020	Consolidated accounts of parent company for subsidiary company period ending 31/12/19 (316 pages)
27 May 2020	Audit exemption subsidiary accounts made up to 31 December 2019 (18 pages)
17 March 2020	Termination of appointment of Richard Green as a director on 10 March 2020 (1 page)
17 March 2020	Termination of appointment of Richard Philip Tattershall as a director on 10 March 2020 (1 page)
20 February 2020	Notice of agreement to exemption from audit of accounts for period ending 31/12/19 (1 page)
20 February 2020	Audit exemption statement of guarantee by parent company for period ending 31/12/19 (3 pages)
27 January 2020	Confirmation statement made on 21 January 2020 with no updates (3 pages)
30 September 2019	Appointment of Mr Nicholas Ian Cooper as a director on 11 September 2019 (2 pages)
30 August 2019	Appointment of Mr Antrinkos Andrew Aristidou as a director on 19 August 2019 (2 pages)
22 August 2019	Full accounts made up to 31 December 2018 (19 pages)
24 January 2019	Confirmation statement made on 21 January 2019 with no updates (3 pages)
15 January 2019	Termination of appointment of Melanie Foster-Hawes as a director on 15 January 2019 (1 page)
15 January 2019	Appointment of Mr Richard Green as a director on 15 January 2019 (2 pages)
1 May 2018	Full accounts made up to 31 December 2017 (17 pages)
29 January 2018	Confirmation statement made on 21 January 2018 with no updates (3 pages)
12 December 2017	Termination of appointment of Jonathan Wilson Box as a director on 30 November 2017 (1 page)
8 December 2017	Appointment of Richard Philip Tattershall as a director on 30 November 2017 (3 pages)
12 June 2017	Full accounts made up to 31 December 2016 (18 pages)
12 June 2017	Full accounts made up to 31 December 2016 (18 pages)
3 February 2017	Confirmation statement made on 21 January 2017 with updates (5 pages)
3 February 2017	Confirmation statement made on 21 January 2017 with updates (5 pages)
22 September 2016	Full accounts made up to 31 December 2015 (17 pages)
22 September 2016	Full accounts made up to 31 December 2015 (17 pages)
2 August 2016	Termination of appointment of Adam Walker as a director on 1 August 2016 (1 page)
2 August 2016	Termination of appointment of Adam Walker as a director on 1 August 2016 (1 page)
2 August 2016	Statement of capital following an allotment of shares on 29 January 2016 GBP 102 (3 pages)
2 August 2016	Statement of capital following an allotment of shares on 29 January 2016 GBP 102 (3 pages)
24 June 2016	Appointment of Mr Jonathan Wilson Box as a director on 17 June 2016 (2 pages)
24 June 2016	Appointment of Mrs Melanie Foster-Hawes as a director on 17 June 2016 (2 pages)
24 June 2016	Appointment of Mrs Melanie Foster-Hawes as a director on 17 June 2016 (2 pages)
24 June 2016	Appointment of Mr Jonathan Wilson Box as a director on 17 June 2016 (2 pages)
1 March 2016	Termination of appointment of Paul Frederick Blackburn as a director on 1 March 2016 (1 page)
1 March 2016	Termination of appointment of Paul Frederick Blackburn as a director on 1 March 2016 (1 page)
2 February 2016	Annual return made up to 21 January 2016 with a full list of shareholders Statement of capital on 2016-02-02 GBP 100 (6 pages)
2 February 2016	Annual return made up to 21 January 2016 with a full list of shareholders Statement of capital on 2016-02-02 GBP 100 (6 pages)
5 June 2015	Appointment of Mr Adam Walker as a director on 3 June 2015 (2 pages)
5 June 2015	Appointment of Mr Adam Walker as a director on 3 June 2015 (2 pages)
5 June 2015	Appointment of Mr Adam Walker as a director on 3 June 2015 (2 pages)
26 January 2015	Current accounting period shortened from 31 January 2016 to 31 December 2015 (1 page)
26 January 2015	Current accounting period shortened from 31 January 2016 to 31 December 2015 (1 page)
21 January 2015	Incorporation Statement of capital on 2015-01-21 GBP 100 (41 pages)
21 January 2015	Incorporation Statement of capital on 2015-01-21 GBP 100 (41 pages)

Haleon UK Holding Sri Lanka Limited

Business Activity

Directors

Contact

Location

Shareholders

Accounts

Returns

Filing History

Contact Companies London